A Phase I study to determine safety, pharmacokinetics, and pharmacodynamics of ANF-RHO™, a novel PEGylated granulocyte colony-stimulating factor, in healthy volunteers.
about
A Phase I study to determine safety, pharmacokinetics, and pharmacodynamics of ANF-RHO™, a novel PEGylated granulocyte colony-stimulating factor, in healthy volunteers.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
A Phase I study to determine s ...... factor, in healthy volunteers.
@en
A Phase I study to determine s ...... factor, in healthy volunteers.
@nl
type
label
A Phase I study to determine s ...... factor, in healthy volunteers.
@en
A Phase I study to determine s ...... factor, in healthy volunteers.
@nl
prefLabel
A Phase I study to determine s ...... factor, in healthy volunteers.
@en
A Phase I study to determine s ...... factor, in healthy volunteers.
@nl
P2093
P2860
P1476
A Phase I study to determine s ...... factor, in healthy volunteers.
@en
P2093
Abraham Abuchowski
Hemant Misra
John Berryman
Ronald Jubin
P2860
P2888
P356
10.1007/S10637-017-0490-8
P577
2017-07-28T00:00:00Z